Detail of "13436-87-8"

CAS Number:
13436-87-8
Name:
Benzamide,2-hydroxy-N-(hydroxymethyl)-
Superlist Name:
N-(Hydroxymethyl)salicylamide
Molecular Structure:
Formula:
C₈H₉NO₃
Molecular Weight:
167.162
Synonyms:
Salicylamide,N-(hydroxymethyl)- (7CI,8CI);N-(Hydroxymethyl)salicylamide;N-Methylolsalicylamide;NSC 30181;
Density:
1.329g/cm³
Boiling Point:
408.6°Cat760mmHg
Flash Point:
200.9°C

Display：

Salicylamide

Supplier:Hangzhou Sage Chemical Co.,Ltd [ China (Mainland)]

Verified-Platinum Supplier 2nd Year Platinum
Supplier 1510 Integral
1510

Tel:+86-571-86818502

Address:5Fl. 501Room, Tower A, New Youth Plaza, 8 Jia Shan Road, Hangzhou, China

Supplier:shanghai sphchem co.,ltd [ China (Mainland)]

630 Integral
630

Tel:+86-21-56491756 13512199871

Address:NO.133, Wuye, Yangxin Road ,Shanghai China

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Discovery of HIV-1 Integrase Inhibitors by Pharmacophore Searching: Discovery of HIV-1 Integrase Inhibitors by Pharmacophore Searching. Hong, Huixiao; Neamati, Nouri; Wang, Shaomeng; Nicklaus, Marc C.; Mazumder, Abhijit; Zhao, He; Burke, Terrence R. Jr.; Pommier, Yves; Milne, George W. A. (Laboratories of Medicinal Chemistry and Molecular Pharmacology, National Cancer Institute, Bethesda, MD 20892-4255, USA). Journal of Medicinal Chemistry, 40(6), 930-936 (English) 1997 American Chemical Society. CODEN: JMCMAR.Several reagents such as 13436-87-8 is used here. ISSN: 0022-2623. DOCUMENT TYPE: Journal CA Section: 1 (Pharmacology) Based upon a class of known HIV-1 integrase inhibitors, several pharmacophore models were proposed from mol. modeling studies and validated using a 3D database of 152 compds. for which integrase assay data are known. Using the most probable pharmacophore model as the query, the NCI 3D database of 206 876 compds. was searched, and 340 compds. that contain the pharmacophore query were identified. Twenty-nine of these compds. were selected and tested in the HIV-1 integrase assay. This led to the discovery of 10 novel, structurally diverse HIV-1 integrase inhibitors, four of which have an IC50 value less than 30 mM and are promising lead compds. for further HIV-1 integrase inhibitor development. .